Use of a cartilage-inducing factor (CIF) for the manufacture of a medicament for treating inflammation

摘要

Inflammation, acute and/or chronic, is treated with a CIF (TGF-β). The CIF may be administered locally or systemically, depending upon the indication, and does not require coadministration of activator or cofactor for efficacy.